Symptom report in detecting breast cancer-related lymphedema

Breast Cancer: Targets and Therapy

Volumn 7, Issue , 2015, Pages 345-352

  Fu, Mei R ^a   Axelrod, Deborah ^b,c   Cleland, Charles M ^a   Qiu, Zeyuan ^d   Guth, Amber A ^b,c   Kleinman, Robin ^b   Scagliola, Joan ^b   Haber, Judith ^a  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Heaviness; Pain; Risk; Screening; Sensitivity; Swelling

Indexed keywords

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; MASTECTOMY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STRUCTURED INTERVIEW;

EID: 84944739752     PISSN: None     EISSN: 11791314     Source Type: Journal    
DOI: 10.2147/BCTT.S87854     Document Type: Article

References (20)

1. McLaughlin SA, Bagaria S, Gibson T, et al. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. J Am Coll Surg. 2013;216:380–389.
2. Fu MR, Kang Y. Psychosocial impact of living with cancer-related lymphedema. Semin Oncol Nurs. 2013;29(1):50–60.
3. Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology. 2013;22(7):1466–1484.
4. Fu MR, Rosedale M. Breast cancer survivors’ experiences of lymphedema-related symptoms. J Pain Symptom Manage. 2009;38: 849–859.
5. Chachaj A, Małyszczak K, Pyszel K, et al. Physical and psychological impairments of women with upper lymphedema following breast cancer treatment. Psychooncology. 2009;19:299–305.
6. Cormier JN, Xing Y, Zaniletti I, Askew RL, Stewart BR, Armer JM. Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology. 2009;42:161–175.
7. Fu MR, Chen CM, Haber J, Guth AA, Axelrod D. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. Ann Surg Oncol. 2010;17(7):1847–1853.
8. Armer JM, Radina ME, Porock D, Culbertson SD, et al. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52(6):370–379.
9. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Lymphology. 2003;36:84–91.
10. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213–5219. doi: 10.1200/JCO.2008.16.3725.
11. Hu S, Cleland CM, Kang Y. Fu MR. Measuring lymphedema symptom burdens: A psychometric study. The Multinational Association of Supportive Care in Cancer’s annual meeting (MASCC/ISOO). In: 2012 International Symposium on Supportive Care in Cancer in New York City; June 28–30, 2012; New York.
12. Shi S, Lu Q, Fu MR, et al. Psychometric properties of the breast cancer and lymphedema symptom experience index: the Chinese version. Eur J Oncol Nurs. Epub 2015 Jun 9.
13. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–35.
14. Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):670–675.
15. Core Team R. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. ISBN 3-900051-07-0, Available from: http://www.R-project.org/. Accessed July 13, 2015.
16. Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer related lymphedema: area under the curve. Arch Phys Med Rehabil. 2011;92:603–610.
17. Welch BL. On the comparison of several mean values: an alternative approach. Biometrika. 1951;38:330–336.
18. Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2007;16:775–782.
19. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95:279–293.
20. Fu MR, Axelrod D, Guth A, et al. Proactive approach to lymphedema risk reduction: a prospective study. Ann Surg Oncol. 2014;21(11): 3481–3498.